Showing results (31-40 of 48) with videos related to
Sort By:
Pageof 5
Pharmacology, Biochemistry, and Behavior|August 1, 1994
Endothelin-C-terminal hexapeptide increases grooming in miceJ Scherrer, J E Morley, J F FloodRevue D'Electroencephalographie Et De Neurophysiologie Clinique|April 1, 1971
[Electroencephalographic problems in a department of infant resuscitation]A Lerique-Koechlin, J Mises, B Sternberg, et al.The American Journal of Physiology|April 1, 1994
Endocrine interactions: adrenal steroids and precursorsG T Taylor, J Scherrer, J Weiss, et al.American Journal of Hospital Pharmacy|November 1, 1982
Documented effectiveness of clinical pharmacy servicesF M Gibson, M L Hyneck, J J ScherrerOsteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 17, 2014
Reference equations for ultrasound bone densitometry of the radius in Central European children and adolescentsM J Scherrer, M K Rochat, D Inci, et al.Critical Reviews in Immunology|October 20, 2001
The identification and development of specific monoclonal antibodies to squamous cell carcinomaM Arlen, A Tsang, J Scherrer, et al.Cancer|August 1, 1985
Specific active immunotherapy in patients with adenocarcinoma of the colon utilizing tumor-associated antigens (TAA). A phase I clinical trialA Hollinshead, E G Elias, M Arlen, et al.Psychopharmacology|June 24, 1999
Neuroleptic influences on a lateralized behavioral bias in unoperated ratsG Taylor, M Bardgett, J Csernansky, et al.Physiology & Behavior|March 1, 1996
Male reproductive systems under chronic fluoxetine or trimipramine treatmentG Taylor, M Bardgett, J Csernansky, et al.Cancer|April 1, 1982
Pilot studies using melanoma tumor-associated antigens (TAA) in specific-active immunochemotherapy of malignant melanomaA Hollinshead, M Arlen, R Yonemoto, et al.Pageof 5